Eulade Rugengamanzi

Eulade Rugengamanzi

Auto-generated profile, based on publicly available information

Eulade Rugengamanzi

Butaro Level II Teaching Hospital, Butaro, Rwanda

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2022 in Heliyon
Verified
Journal Article
Open access
EEEgide EGIDE
Egide EGIDE
Elisephane IRANKUNDAElisephane IRANKUNDA
Elisephane IRANKUNDA
EREulade Rugengamanzi
Eulade Rugengamanzi
MAMabano Amani
Mabano Amani
Noise pollution poses a serious threat to public health and continues to grow in extent, frequency, and severity due to the rapid population growth and urbanization, and this is of particular concern in developing countries such as Rwanda. However, data on noise pollution levels, noise laws and regulations are, however, lacking in Rwanda. We assessed the effect of land-use type during a two-month period at nine sites: three commercial sites, three passenger-car parking sites, two road junction sites, and one reference site (Car-Free Zone) in Rwanda. We collected data on noise pollution during weekdays (Monday, Wednesday, and Friday) and Weekends (Saturday and Sunday) in the morning (7h00–10h00), around noon (11h00–14h00), and in the evening (15h00–18h00). The mean noise levels were higher during weekdays (60–80) A-weighted decibels (dB) (A)) than during weekends (50–70 dB (A)). We recorded the lowest noise level at Kigali car-free zone in the morning (34.4 dB (A)) and the highest noise level at Nyabugogo passenger-car parks in the evening (111.2dB (A)). Spatial variation of noise levels interpolated for Kigali City shows higher noise levels (hotspot) in the outskirts of Kigali, Remera and Kimironko. Noise levels recorded in Kigali exceeded the World Health Organization permissible daytime limits during both weekdays and weekends at all land-use types except the car-free zone site. Our results indicate that Kigali residents are exposed to high levels of noise, and urgent development of noise pollution monitoring programs and control measures in Rwanda is required.

4 April 2025 in The Oncologist
Verified
Journal Article
Open access
RDRebecca J DeBoer
Rebecca J DeBoer
CWChiara A Wabl
Chiara A Wabl
BMBeatrice P Mushi
Beatrice P Mushi
PUPacifique Uwamahoro
Pacifique Uwamahoro
RARaymond Athanas
Raymond Athanas
VCVincent K Cubaka
Vincent K Cubaka
Background: Cancer care involves disclosing difficult information, making treatment decisions, and advance care planning. Communication practices and preferences are strongly influenced by sociocultural context. This scoping review aims to identify, map, and appraise the available evidence on clinical communication in cancer care in Africa and recommend priorities for future work. Methods: A search strategy was developed to identify studies conducted in Africa with a primary focus on patient-clinician communication in cancer care and performed in PubMed, Embase, Web of Science, CINAHL, African Index Medicus, and PsycINFO. Two reviewers independently screened titles and abstracts, full texts, and cited references. Study characteristics were analyzed using descriptive statistics and content analysis. Critical appraisal was performed using the Mixed Methods Appraisal Tool. Results: Our search yielded 58 articles from 19 countries. Study designs were quantitative survey (53%), qualitative (38%), non-randomized experimental (5%), and mixed methods (3%), with no randomized trials. Populations included patients with cancer (n = 25), doctors (n = 24), nurses (n = 16), family/caregivers (n = 16), and/or others. Seven studies (12%) focused on pediatrics. Most studies (60%) focused on clinicians’ disclosure of information, often framed as “breaking bad news” or “truth-telling.” The remainder focused on information preferences (14%), advance care planning (10%), illness understanding (5%), shared decision making (5%), and communication training (3%). Critical appraisal demonstrated higher quality among qualitative than quantitative studies. Conclusions: Future work should explore underexamined research areas such as patient-centered communication, translate observational findings into intervention development and testing, implement communication skills training, and evaluate outcomes related to communication in cancer care in Africa.

4 March 2023 in Journal of Cancer Policy
Verified
Journal Article
Closed access
FRFidel Rubagumya
Fidel Rubagumya
JGJacqueline Galica
Jacqueline Galica
EREulade Rugengamanzi
Eulade Rugengamanzi
BNBrandon A. Niyibizi
Brandon A. Niyibizi
AAAjay Aggarwal
Ajay Aggarwal
CBChristopher Booth
Christopher Booth

24 November 2024 in npj Genomic Medicine
Verified
Journal Article
Open access
PDF file
AMAchille V. C. VC. Manirakiza
Achille V. C. VC. Manirakiza
SBShakuntala Baichoo
Shakuntala Baichoo
AUAnnette UWINEZA
Annette UWINEZA
DDDamas Dukundane
Damas Dukundane
FUFrancois Uwinkindi
Francois Uwinkindi
TRTimothy R. Rebbeck
Timothy R. Rebbeck
Cancer genetic data from Sub-Saharan African (SSA) are limited. Patients with female breast (fBC), male breast (mBC), and prostate cancer (PC) in Rwanda underwent germline genetic testing and counseling. Demographic and disease-specific information was collected. A multi-cancer gene panel was used to identify germline Pathogenic Variants (PV) and Variants of Uncertain Significance (VUS). 400 patients (201 with BC and 199 with PC) were consented and recruited to the study. Data was available for 342 patients: 180 with BC (175 women and 5 men) and 162 men with PC. PV were observed in 18.3% fBC, 4.3% PC, and 20% mBC. BRCA2 was the most common PV. Among non-PV carriers, 65% had ≥1 VUS: 31.8% in PC and 33.6% in BC (female and male). Our findings highlight the need for germline genetic testing and counseling in cancer management in SSA.

1 August 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAlita Mrema
Alita Mrema
MNMamsau Ngoma
Mamsau Ngoma
ELEmmanuel Lugina Lugina
Emmanuel Lugina Lugina
AKAtukuzwe Kahakwa
Atukuzwe Kahakwa
CMChacha Josiah Mwita
Chacha Josiah Mwita
JMJulius Mwaiselage
Julius Mwaiselage
Background: Cervical cancer (CC) is the leading cancer among women in Tanzania, especially among those between the ages of 15 and 44. The prevalence of high-risk Human papillomavirus (HR-HPV)-16/18 women in the general population at any given time is 3.3%. HR-HPVs 16 or 18 are the primary cause of CC. The distribution of HPV genotypes among women with CC according to HIV status is unknown in Tanzania. This study aimed to determine the HPV genotype distribution according to HIV status among women with CC in Tanzania. Methods: This cross-sectional study was done at Ocean Road Cancer Institute (ORCI) in Tanzania among women with histologically confirmed CC. HIV serology testing was performed. Biopsy was taken from cervical lesions, and DNA was extracted. HPV DNA was amplified by using a previously validated multiplex HPV PCR assay targeting 14 high-risk HPV genotypes (16,18,30,31,33, 35, 39, 45, 51, 52, 56, 58, 59, and 66) and two low‐risk HPV genotypes (6 and 11). Continuous variables were compared using either a student t-test or the Mann-Whitney U test. Fisher’s exact test was employed to compare discrete variables. A P-value less than 0.05 was considered statistically significant. Results: We included 100 women with CC. The prevalence of HIV infection in this study was 42%. The prevalence of any HPV infection was 94%, ranging from 1–3 genotypes per woman. HPV. The median age for women living with HIV (WLWH) with CC patients was 45 years (IQR, 31–60), while the median age for HIV-uninfected women with CC patients was 57 years (IQR, 30–78). (p = 0.0001). WLWH and HIV-uninfected women had similar HPV prevalence, except for HPV 35, which was more common in WLWH. There was a trend of high prevalence of HPV 52 and HPV 58 in WLHH compared to HIV-uninfected women, but this difference was not statistically significant. The prevalence of HPV 16 and/or 18 infection in the entire sample was 85%. The combined prevalence of HPV 16 and/or 18 was 76% WLWH and 91% amongst HIV-uninfected women (p = 0.036).The majority of women (77.9%) had single-genotype HPV infection. There was no difference in the distribution of multiple or single HPV genotypes infection by HIV status (p = 0.25). Conclusion: In this study, HIV positive women with CC presented at a significantly younger age (45 years) compared to the HIV-negative women (57 years). The prevalence of high-risk HPV is high among women with CC in Tanzania. Distribution of most high-risk HPV genotypes among women with CC was not significantly influenced by HIV status except for HPV 35, which appeared to be more in HIV positive women compared to HIV-negative women. While the majority of the high-risk HPV infections were with single HPV genotypes, the prevalence of multiple high-risk HPV infections was at 22%, with no significant difference between the two HIV statuses. A vaccination program that aptly targets HPV 16 and 18 could prevent up to 85% of CC cases in Tanzania, regardless of HIV. Keywords: Human papillomavirus, cervical cancer, HIV, Tanzania.

1 December 2024 in JCO Global Oncology
Verified
Journal Article
Open access
FRFidel Rubagumya
Fidel Rubagumya
LCLaura Carson
Laura Carson
DADaniel Afolayan
Daniel Afolayan
EREulade Rugengamanzi
Eulade Rugengamanzi
GNGodwin Abdiel Nnko
Godwin Abdiel Nnko
NHNazik Hammad
Nazik Hammad
PURPOSE: Cancer continues to be a significant public health concern. Sub-Saharan Africa (SSA) struggles with a lack of proper infrastructure and adequate cancer care workforce. This has led to some countries relying on referrals of cancer care to countries with higher income levels. In some instances, patients refer themselves. Some countries have made it their goal to attract patients from other countries, a term that has been referred to as medical tourism. In this article, we explore the current status of oncology-related medical tourism in SSA. METHODS: This was a cross-sectional study. The study participants included oncologists, surgeons, and any other physicians who take care of patients with cancer. A predesigned questionnaire was distributed through African Organization for Research and Training in Cancer member mailing list and through study team personal contacts and social media. RESULTS: A total of 52 participants from 17 African countries with a 1.6:2 male to female ratio responded to the survey. Most (55.8%) of the respondents were from Eastern African countries. The majority (92%) of study participants reported that they knew patients who referred themselves abroad, whereas 75% referred patients abroad, and the most common (94%) referral destination was India. The most common (93%) reason for referral was perception of a higher quality of care in foreign health institutions. CONCLUSION: The findings suggest the need to improve local health care systems including building trust of the system among general population. The study highlights potential financial toxicity, and it adds to the current emphasis on return of investment on homegrown workforce and cancer treatment infrastructure.